drugset / Trial / NCT05704673

Effect of IV Nalbuphine on Nausea and Vomiting Following Intrathecal Morphine

NCT05704673

Unknown 80 enrolled Assiut University
RandomizedParallel-groupSingle-blindPrevention

Summary

the study aimed to investigate the effect of Iv nalbuphine on postoperative nausea and vomiting and pain with intrathecal morphine on inguinal hernia repair surgery.

Timeline

Start
2023-06-01
Primary completion
2023-12
Completion
2024-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Nalbuphine Small molecule 0.5 mg Intravenous
Comparator Morphine Other / unclassified 0.2 mg Intrathecal

Indications

No indication recorded.